Scholarlink

<p>Certain intracellular pathogens can reside within cells to evade host immune defenses and exhibit high tolerance to antibiotics. Current treatments for intracellular bacterial infections are limited by poor cellular penetration, inadequate targeting of infected sites, and inefficacy against drug-resistant bacteria. Here, peptide dendron nanoassemblies comprising self-assembling regions, cell-penetrating motifs, enzyme-responsive sequences, and targeting ligands are developed to eliminate intracellular drug-resistant bacteria. The peptide dendrons self-assemble into nanoparticles that bind to membrane integrins via targeting sequence. The receptor-ligand interaction triggers a structural transformation into nanofibers for prolonged retention on the membrane surfaced of infected cells. Subsequently, they transform to nanoparticles upon tailored by bacteria-secreted enzyme, facilitating cellular uptake to target and eradicate intracellular drug-resistant bacteria. Self-assembling peptide dendrons further enhance macrophage resistance to infection-induced damage by modulating ferroptosis. The in vivo efficacy of peptide dendron nanoassemblies in removing intracellular drug-resistant bacteria is demonstrated in male mice and piglet infection models. This study provides a promising therapeutic strategy for treating intracellular drug-resistant infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Enzyme-responsive peptide dendron nanoassemblies for targeting and eliminating intracellular drug-resistant bacteria

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月13日

查看全文
  • Qi Tang,
  • Peng Tan,
  • Chenlong Zhou,
  • Guanghui Zhao,
  • Shuaikang Yang,
  • Yucheng Zhang,
  • Tao Wang,
  • Zhenduo Chen,
  • Xi Ma

摘要

Certain intracellular pathogens can reside within cells to evade host immune defenses and exhibit high tolerance to antibiotics. Current treatments for intracellular bacterial infections are limited by poor cellular penetration, inadequate targeting of infected sites, and inefficacy against drug-resistant bacteria. Here, peptide dendron nanoassemblies comprising self-assembling regions, cell-penetrating motifs, enzyme-responsive sequences, and targeting ligands are developed to eliminate intracellular drug-resistant bacteria. The peptide dendrons self-assemble into nanoparticles that bind to membrane integrins via targeting sequence. The receptor-ligand interaction triggers a structural transformation into nanofibers for prolonged retention on the membrane surfaced of infected cells. Subsequently, they transform to nanoparticles upon tailored by bacteria-secreted enzyme, facilitating cellular uptake to target and eradicate intracellular drug-resistant bacteria. Self-assembling peptide dendrons further enhance macrophage resistance to infection-induced damage by modulating ferroptosis. The in vivo efficacy of peptide dendron nanoassemblies in removing intracellular drug-resistant bacteria is demonstrated in male mice and piglet infection models. This study provides a promising therapeutic strategy for treating intracellular drug-resistant infections.